Radio Taiwan International
Date: 2018-04-25

The Food and Drug Administration (FDA) has signed an agreement with the National Pharmaceutical Regulatory Agency of Malaysia to further collaboration on projects in the medical field.

The move is the FDA’s latest effort to promote the government’s New Southbound policy. The policy aims to build closer cultural and economic ties with countries in South and Southeast Asia, as well as Australia and New Zealand.

FDA director-general Wu Shou-mei said the agreement allows medical professionals from Taiwan and Malaysia to collaborate in many areas. They include the exchange of technical information on drug regulation, sharing experience on legal issues, as well as scheduling regular seminars to promote mutual understanding.

Wu also said that Southeast Asian nations present a large untapped market for Taiwan’s medical products, including drugs, medical equipment, cosmetics and nutritional supplements.    [FULL  STORY]